In this study, we showed that mutation of MORC2 O-GlcNAcylation site (T556A) or pharmacological inhibition of OGT by OSMI-1 impairs MORC2-mediated breast cancer cell migration and invasion in vitro and lung colonization in a mouse xenograft mouse model (Fig. 3). Here, MORC2 is linked to breast carcinoma.